Using A Natural DNA Repair Process to Improve Genetic Medicines

Daniel Gruskin, chief medical officer of LogicBio, discusses the company’s platform technology, the advantages it provides, and the company’s lead experimental therapy for the rare metabolic condition methylmalonic acidemia.